Showing results (481-490 of 993) with videos related to
Sort By:
Pageof 100
Cancer Research|January 10, 2018
PD2/PAF1 at the Crossroads of the Cancer NetworkSaswati Karmakar, Parama Dey, Arokia P Vaz, et al.Frontiers in Immunology|October 26, 2017
Multifaceted Role of Neuropilins in the Immune System: Potential Targets for ImmunotherapySohini Roy, Arup K Bag, Rakesh K Singh, et al.Journal of Experimental & Clinical Cancer Research : CR|December 21, 2018
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targetingRamesh Pothuraju, Satyanarayana Rachagani, Wade M Junker, et al.Pharmaceutical Research|February 1, 1987
Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dogM Bialer, V K Batra, J A Morrison, et al.Seminars in Cancer Biology|March 29, 2022
Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancerKoelina Ganguly, Ashu Shah, Pranita Atri, et al.The Prostate|March 1, 2002
Establishment and characterization of androgen-independent human prostate cancer LNCaP cell modelTsukasa Igawa, Fen-Fen Lin, Ming-Shyue Lee, et al.Plos One|September 23, 2009
The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progressionNicolas Moniaux, Christophe Nemos, Shonali Deb, et al.Cancer Research|November 18, 2008
MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cellsSangeeta Bafna, Ajay P Singh, Nicolas Moniaux, et al.British Journal of Clinical Pharmacology|January 3, 2001
Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidineT Kosoglou, M Salfi, J M Lim, et al.Biochemistry|August 2, 2001
Mechanism of specific target recognition and RNA hydrolysis by ribonucleolytic toxin restrictocinS K Nayak, S Bagga, D Gaur, et al.Pageof 100